A citation-based method for searching scientific literature

Maxime Meloche, Hyuk J Kwon, Nathalie Letarte, Jean-François Bussières, Barbara Vadnais, Thierry Hurlimann, Annie Lavoie, Marie-France Beauchesne, Simon de Denus. Pharmacogenomics 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
266
100


Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Susanne B Haga, Julianne M O'Daniel, Genevieve M Tindall, Isaac R Lipkus, Robert Agans. Genet Med 2011
40
50

Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey.
Nataša Karas Kuželički, Irena Prodan Žitnik, David Gurwitz, Adrian Llerena, Ingolf Cascorbi, Sofia Siest, Maurizio Simmaco, Marc Ansari, Mario Pazzagli, Chiara Di Resta,[...]. Pharmacogenomics 2019
21
50


Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.
Lejla Mahmutovic, Betul Akcesme, Camil Durakovic, Faruk Berat Akcesme, Aida Maric, Muhamed Adilovic, Nour Hamad, Matthias Wjst, Oliver Feeney, Sabina Semiz. Hum Genomics 2018
7
50

Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece.
Yuan Mai, Christina Mitropoulou, Xanthi E Papadopoulou, Athanassios Vozikis, David N Cooper, Ron H van Schaik, George P Patrinos. Per Med 2014
22
50

Public knowledge of and attitudes toward genetics and genetic testing.
Susanne B Haga, William T Barry, Rachel Mills, Geoffrey S Ginsburg, Laura Svetkey, Jennifer Sullivan, Huntington F Willard. Genet Test Mol Biomarkers 2013
128
50

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
158
50

Predictive genetic testing for complex diseases: a public health perspective.
C Marzuillo, C De Vito, E D'Andrea, A Rosso, P Villari. QJM 2014
12
50

Medical student preparedness for an era of personalized medicine: findings from one US medical school.
Caroline Eden, Kipp W Johnson, Omri Gottesman, Erwin P Bottinger, Noura S Abul-Husn. Per Med 2016
18
50

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
95
50




What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
Stavroula Siamoglou, Maria Koromina, Foong-Ming Moy, Christina Mitropoulou, George P Patrinos, Konstantinos Vasileiou. OMICS 2021
1
100

A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece.
Yuan Mai, Theodora Koromila, Aggeliki Sagia, David N Cooper, Georgios Vlachopoulos, George Lagoumintzis, Panagoula Kollia, Konstantinos Poulas, Vlassios Stathakopoulos, George P Patrinos. Per Med 2011
32
50

Rural Community Perceptions and Interests in Pharmacogenomics.
John Stegelmeier, Christopher Nartker, Charles Barnes, Hugo Rayo, Rebecca Hoover, Julia Boyle, Shanna O'Connor, Jared Barrott. Healthcare (Basel) 2020
1
100

Awareness and attitude of the public toward personalized medicine in Korea.
Iyn-Hyang Lee, Hye-Young Kang, Hae Sun Suh, Sukhyang Lee, Eun Sil Oh, Hotcherl Jeong. PLoS One 2018
8
50


Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective.
Tessel Rigter, Marleen E Jansen, Jordy M de Groot, Susan W J Janssen, Wendy Rodenburg, Martina C Cornel. Front Genet 2020
7
50

Human Leukocyte Antigen Gene Testing and Carbamazepine-Induced Toxic Epidermal Necrolysis: A Study of Pediatric Practice.
Jessica M S Asgarpour, Lauren M Lam, Tina K Vogel, Helly R Goez, Loretta Fiorillo. J Cutan Med Surg 2021
1
100

Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research.
Lawrence A Palinkas, Sarah M Horwitz, Carla A Green, Jennifer P Wisdom, Naihua Duan, Kimberly Hoagwood. Adm Policy Ment Health 2015
50

Three approaches to qualitative content analysis.
Hsiu-Fang Hsieh, Sarah E Shannon. Qual Health Res 2005
50

Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
Larissa Waldman, Cheryl Shuman, Iris Cohn, Amy Kaiser, David Chitayat, Syed Wasim, Allison Hazell. Pharmacogenomics 2019
4
50

Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Lucas M Walden, Eva J Brandl, Amtul Changasi, Jessica E Sturgess, Alexander Soibel, Janna Fe D Notario, Sheraz Cheema, Nicole Braganza, Victoria S Marshe, Natalie Freeman,[...]. Psychiatry Res 2015
27
50

Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia.
Samantha Breaux, Francis Arthur Derek Desrosiers, Mauricio Neira, Sunita Sinha, Corey Nislow. J Pers Med 2020
6
50

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
56
50

Personalized medicine could transform healthcare.
Sunil Mathur, Joseph Sutton. Biomed Rep 2017
38
50

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
482
50

Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing.
Sinead Cuffe, Henrique Hon, Xin Qiu, Kimberly Tobros, Chung-Kwun Amy Wong, Bradley De Souza, Graham McFarlane, Sohaib Masroor, Abul K Azad, Ekta Hasani,[...]. Pharmacogenet Genomics 2014
21
50


Positive perception of pharmacogenetic testing for psychotropic medications.
Matthew B Lanktree, Gwyneth Zai, Laura E Vanderbeek, Daniel E Giuffra, David S Smithson, Lucas B Kipp, Timothy R Dalseg, Mark Speechley, James L Kennedy. Hum Psychopharmacol 2014
11
50

Pharmacogenetics: implementing personalized medicine.
Enrico Mini, Stefania Nobili. Clin Cases Miner Bone Metab 2009
26
50

Saturation in qualitative research: exploring its conceptualization and operationalization.
Benjamin Saunders, Julius Sim, Tom Kingstone, Shula Baker, Jackie Waterfield, Bernadette Bartlam, Heather Burroughs, Clare Jinks. Qual Quant 2018
50

Prerequisites to implementing a pharmacogenomics program in a large health-care system.
K D Levy, B S Decker, J S Carpenter, D A Flockhart, P R Dexter, Z Desta, T C Skaar. Clin Pharmacol Ther 2014
26
50

Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine.
James S Green, Travis J O'Brien, Vincent A Chiappinelli, Arthur F Harralson. Pharmacogenomics 2010
53
50

On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
N Amara, J Blouin-Bougie, D Bouthillier, J Simard. Pharmacogenomics J 2018
17
50

Business Modeling to Implement an eHealth Portal for Infection Control: A Reflection on Co-Creation With Stakeholders.
Maarten van Limburg, Jobke Wentzel, Robbert Sanderman, Lisette van Gemert-Pijnen. JMIR Res Protoc 2015
21
50

Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
S J Bielinski, J L St Sauver, J E Olson, M L Wieland, C R Vitek, E J Bell, M E Mc Gree, D J Jacobson, J B McCormick, P Y Takahashi,[...]. Pharmacogenomics J 2017
18
50

Stakeholder views on pharmacogenomic testing.
Haridarshan N Patel, Iulia D Ursan, Patrick M Zueger, Larisa H Cavallari, A Simon Pickard. Pharmacotherapy 2014
34
50

Knowledge and opinions among Canadian academic physicians regarding genetic screening to prevent severe cutaneous adverse drug reactions.
Felix L Chan, Neil H Shear, Anuysha Maharaj, Cristina Olteanu, Rena Hashimoto, Michael Ziv, Roni P Dodiuk-Gad. J Am Acad Dermatol 2019
3
50

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
Nina R Sperber, Janet S Carpenter, Larisa H Cavallari, Laura J Damschroder, Rhonda M Cooper-DeHoff, Joshua C Denny, Geoffrey S Ginsburg, Yue Guan, Carol R Horowitz, Kenneth D Levy,[...]. BMC Med Genomics 2017
52
50


Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario.
Basil G Bereza, Doug Coyle, Derek Y So, Zbigniew Kadziola, George Wells, Paul Grootendorst, Emmanuel A Papadimitropoulos. Clinicoecon Outcomes Res 2020
2
50

Precision Medicine: Changing the way we think about healthcare.
Gustavo Rosa Gameiro, Viktor Sinkunas, Gabriel Romero Liguori, José Otavio Costa Auler-Júnior. Clinics (Sao Paulo) 2018
16
50

An evaluation of pharmacists' expectations towards pharmacogenomics.
Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, Barbara Vadnais. Pharmacogenomics 2013
53
50

Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.
Lori Kay Mattison, Jeanne Fourie, Renee A Desmond, Anil Modak, Muhammad Wasif Saif, Robert B Diasio. Clin Cancer Res 2006
99
50

Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
Chloé Petit, Audrey Croisetière, Flora Chen, Isabelle Laverdière. Pharmacogenomics 2020
5
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.